Your browser doesn't support javascript.
loading
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
Goff, Peter H; Hayashi, Tomoko; Martínez-Gil, Luis; Corr, Maripat; Crain, Brian; Yao, Shiyin; Cottam, Howard B; Chan, Michael; Ramos, Irene; Eggink, Dirk; Heshmati, Mitra; Krammer, Florian; Messer, Karen; Pu, Minya; Fernandez-Sesma, Ana; Palese, Peter; Carson, Dennis A.
Afiliação
  • Goff PH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Hayashi T; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Martínez-Gil L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Corr M; Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Crain B; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Yao S; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Cottam HB; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Chan M; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Ramos I; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Eggink D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Heshmati M; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Messer K; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Pu M; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Fernandez-Sesma A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA peter.palese@mssm.edu dcarson@ucsd.edu.
  • Carson DA; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA peter.palese@mssm.edu dcarson@ucsd.edu.
J Virol ; 89(6): 3221-35, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25568203
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Adjuvantes Imunológicos / Receptor 4 Toll-Like / Receptor 7 Toll-Like / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Proteção Cruzada Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Adjuvantes Imunológicos / Receptor 4 Toll-Like / Receptor 7 Toll-Like / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Proteção Cruzada Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos